Pearson-Smith, Jennifer N.
Liang, Li-Ping
Rowley, Shane D.
Day, Brian J.
Patel, Manisha
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (UO1NS083422)
National Institute of Neurological Disorders and Stroke (F31NS086405)
National Institute of Neurological Disorders and Stroke (R21NS072099)
Article History
Received: 9 February 2017
Revised: 11 April 2017
Accepted: 18 April 2017
First Online: 2 May 2017
Compliance with Ethical Standards
:
: Drs. Day and Patel are consultants for Aeolus Pharmaceuticals which develops catalytic antioxidants for human diseases including the compound used in this work. Dr. Day holds equity in Aeolus Pharmaceuticals.